1. Home
  2. ECF vs NYXH Comparison

ECF vs NYXH Comparison

Compare ECF & NYXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ellsworth Growth and Income Fund Ltd.

ECF

Ellsworth Growth and Income Fund Ltd.

HOLD

Current Price

$12.66

Market Cap

173.6M

Sector

Finance

ML Signal

HOLD

Logo Nyxoah SA

NYXH

Nyxoah SA

HOLD

Current Price

$2.91

Market Cap

152.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ECF
NYXH
Founded
1986
2009
Country
United States
Belgium
Employees
N/A
N/A
Industry
Finance/Investors Services
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
173.6M
152.8M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
ECF
NYXH
Price
$12.66
$2.91
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$9.33
AVG Volume (30 Days)
27.6K
25.2K
Earning Date
01-01-0001
05-12-2026
Dividend Yield
6.42%
N/A
EPS Growth
N/A
N/A
EPS
0.46
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$213.98
Revenue Next Year
N/A
$126.25
P/E Ratio
$27.52
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.15
$2.76
52 Week High
$12.73
$8.64

Technical Indicators

Market Signals
Indicator
ECF
NYXH
Relative Strength Index (RSI) 67.54 39.15
Support Level $11.67 $2.78
Resistance Level N/A $3.37
Average True Range (ATR) 0.20 0.13
MACD 0.04 0.00
Stochastic Oscillator 83.51 3.57

Price Performance

Historical Comparison
ECF
NYXH

About ECF Ellsworth Growth and Income Fund Ltd.

Ellsworth Growth and Income Fund Ltd operate as a closed-end, diversified management investment company. Its investment objective is to provide income and the potential for capital appreciation, which objectives the Fund considers to be relatively equal over the long term due to the nature of the securities in which it invests. The company invests in convertible and equity securities. It invests in various sectors, such as healthcare, financial services, computer software and services, energy and utilities, real estate investment trusts, semiconductors, telecommunications, business services, food and beverage, consumer products, transportation, consumer services among others.

About NYXH Nyxoah SA

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

Share on Social Networks: